ArticleFrontiers in medicine2026

Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity.

Qiuhui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.